Skip to main content
Caplight Logo









Igentify

Igentify

Private
IsraelHealthcare & Life Scienceshttps://igentify.com/

Last Round

Series A

Sep 16, 2019

Total Funding Raised

$10.55M

Company Overview

Igentify is a health tech company that provides a digital platform for genetic counseling, automating workflows for clinical and non-clinical genetic testing.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Workflow Automation, Medical Devices, Data Integration, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital healthworkflow automationpatient engagementgenetic counselingclinical data integrationprecision medicinehealth techelectronic medical recordEMRclinical automationSaaSmedical deviceAI in healthcarepatient communicationdigital advisor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Igentify Comparables

Compare Igentify with similar companies based on industry and business-model similarity.

Igentify comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
My Gene Counsel
83%
Genetics Adviser
82%
Metis Genetics
81%

Igentify Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 16, 2019
GrantAug 1, 2019
GrantJul 8, 2019

Key People

Founding team and executive leadership

Elliott Greenspan

Chief Innovation Officer, Co-Founder

Founding Team

Doron M Behar

Founder and Chief Executive Officer (CEO)

Founding Team

Ofir A.

Chief Product Officer

Executive Team

Igentify Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors increased 38% MoM.

  • Feb 2, 2026

    Monthly visitors grew 360% MoM, reaching 5.1K.

Igentify Filings

Explore SEC and related filing metadata, where available.

Igentify filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Igentify's valuation, stock price, and market status.

Is Igentify a public or private company?

Igentify is a private company.

What is the current stock price of Igentify?

Igentify is a private company with no public stock price. No recent secondary market data is available.

How much is Igentify worth (valuation)?

Valuation information for Igentify is not publicly available.

Can I buy Igentify stock?

Igentify shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Igentify's last funding round?

Igentify's most recent funding round was Series A on September 16, 2019.

Who are the main investors in Igentify?

Key investors in Igentify include Horizon 2020, BIRD Foundation, aMoon.

Will Igentify IPO soon?

No public IPO plans have been announced for Igentify.

How can I track Igentify secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Igentify's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range42
Year Founded2016
Last FundingSep 16, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?